Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335218
Status:
COMPLETED
Last Update Posted:
2014-12-30
First Post:
2006-02-24
Brief Title:
Fat Distribution in Healthy Early Postmenopausal Women
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A Multi-center Prospective Randomized Double-blind Placebo-controlled Two-arm Phase IV Study to Investigate the Influence of a Continuous Combined Estrogen-progestin Regimen Containing 2 mg Estradiol Valerate and 2 mg Dienogest Climodien Lafamme on the Fat Distribution in Otherwise Healthy Early Postmenopausal Women
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to explore the effects of hormone replacement therapy with EVDNG on abdominal fat distribution measured by magnetic resonance imaging
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG GermanyBayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 306387 | None | None | None |